EPZ015666 2 mg | 99.29%
TargetMol
EPZ015666 is an orally available inhibitor of PRMT5 enzymatic activity.
More Information Supplier PageEPZ015666
Search Results
AZD 6482 5 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
AZD 6482 50 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
AZD 6482 2 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
AZD 6482 25 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
AZD 6482 10 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
EPZ015666 5 mg | 99.29%
TargetMol
EPZ015666 is an orally available inhibitor of PRMT5 enzymatic activity.
More Information Supplier PageEPZ015666
EPZ015666 50 mg | 99.29%
TargetMol
EPZ015666 is an orally available inhibitor of PRMT5 enzymatic activity.
More Information Supplier PageEPZ015666
Sulfatinib 5 mg | 98.93%
TargetMol
Sulfatinib (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 and CSF1R with IC 50 s ranging from 1 to 24 nM.
More Information Supplier PageSulfatinib
Reparixin 10 mg | 98.00%
TargetMol
Reparixin is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM).
More Information Supplier PageReparixin
